Accuray Company Profile (NASDAQ:ARAY)

About Accuray

Accuray logoAccuray Incorporated is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. Its suite of products includes the CyberKnife Systems and the TomoTherapy Systems. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy and adaptive radiation therapy. Its principal radiosurgery products, the CyberKnife Systems are robotic full-body radiosurgery system designed to treat tumors anywhere in the body non-invasively, which include the CyberKnife M6 Series with configuration options of fixed collimators plus iris variable aperture collimator, fixed collimators plus the InCise MLC and fixed collimators plus iris variable aperture collimator and the InCise MLC. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ARAY
  • CUSIP: 00439710
Key Metrics:
  • Previous Close: $5.84
  • 50 Day Moving Average: $5.46
  • 200 Day Moving Average: $5.44
  • 52-Week Range: $81,574,000.00 - $4.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 40.43
  • P/E Growth: 0.13
  • Market Cap: $461.71M
  • Outstanding Shares: 81,574,000
  • Beta: 1.5
  • Net Margins: -5.55%
  • Return on Equity: -35.82%
  • Return on Assets: -4.67%
  • Debt-to-Equity Ratio: 2.86%
  • Current Ratio: 1.72%
  • Quick Ratio: 1.17%
Additional Links:
Companies Related to Accuray:

Analyst Ratings

Consensus Ratings for Accuray (NASDAQ:ARAY) (?)
Ratings Breakdown: 1 Sell Rating, 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.17)
Consensus Price Target: $9.13 (61.22% upside)

Analysts' Ratings History for Accuray (NASDAQ:ARAY)
DateFirmActionRatingPrice TargetDetails
9/13/2016Cowen and CompanyInitiated CoverageOutperform$9.00View Rating Details
8/18/2016Morgan StanleySet Price TargetHold$8.00View Rating Details
5/22/2016Brean CapitalReiterated RatingBuy$12.00View Rating Details
2/1/2016BTIG ResearchReiterated RatingNeutralView Rating Details
1/29/2016Royal Bank Of CanadaLower Price TargetSector Perform$8.00 -> $7.50View Rating Details
11/12/2015Citigroup Inc.Initiated CoverageSellView Rating Details
5/1/2015Dougherty & CoLower Price TargetBuy$10.75 -> $9.00View Rating Details
4/1/2015SidotiInitiated CoverageBuy$12.00View Rating Details
1/12/2015Northland SecuritiesInitiated CoverageOutperform$11.00View Rating Details
12/15/2014SunTrust Banks Inc.Initiated CoverageNeutralView Rating Details
(Data available from 9/25/2014 forward)


Earnings History for Accuray (NASDAQ:ARAY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/17/2016Q316($0.07)($0.09)$98.97 million$95.00 millionViewListenView Earnings Details
4/26/2016Q316($0.06)$0.01$102.79 million$105.30 millionViewListenView Earnings Details
1/28/2016Q216($0.08)($0.08)$101.15 million$108.90 millionViewListenView Earnings Details
10/29/2015Q116($0.14)($0.12)$88.60 million$89.60 millionViewListenView Earnings Details
8/20/2015Q415($0.04)($0.07)$102.41 million$101.80 millionViewListenView Earnings Details
4/30/2015Q315($0.06)($0.04)$102.72 million$97.50 millionViewListenView Earnings Details
1/27/2015Q215($0.08)($0.13)$98.87 million$98.20 millionViewListenView Earnings Details
10/29/2014Q115($0.13)($0.28)$88.90 million$82.40 millionViewListenView Earnings Details
8/21/2014Q414($0.07)($0.13)$92.23 million$102.00 millionViewListenView Earnings Details
4/30/2014Q314($0.16)($0.06)$82.00 million$97.10 millionViewListenView Earnings Details
1/30/2014Q214($0.20)($0.07)$80.20 million$93.60 millionViewListenView Earnings Details
11/7/2013Q114($0.20)($0.21)$79.67 million$76.60 millionViewListenView Earnings Details
8/27/2013Q4 2013($0.20)($0.20)$82.29 million$84.90 millionViewListenView Earnings Details
5/7/2013Q3 2013($0.22)($0.37)$77.97 million$70.55 millionViewListenView Earnings Details
2/6/2013Q2 2013($0.33)($0.30)$74.23 million$77.80 millionViewListenView Earnings Details
11/7/2012Q113($0.22)($0.23)$85.41 million$83.00 millionViewN/AView Earnings Details
9/6/2012Q412($0.12)($0.20)$106.92 million$100.50 millionViewN/AView Earnings Details
5/8/2012($0.14)($0.21)ViewN/AView Earnings Details
11/8/2011($0.29)($0.38)ViewN/AView Earnings Details
9/19/2011$0.02($0.40)ViewN/AView Earnings Details
5/5/2011$0.04($0.02)ViewN/AView Earnings Details
1/27/2011($0.01)$0.07ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Accuray (NASDAQ:ARAY)
Current Year EPS Consensus Estimate: $-0.14 EPS
Next Year EPS Consensus Estimate: $0.14 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q4 20161($0.08)($0.08)($0.08)
Q1 20171($0.10)($0.10)($0.10)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.05)($0.05)($0.05)
Q4 20171$0.02$0.02$0.02
(Data provided by Zacks Investment Research)


Dividend History for Accuray (NASDAQ:ARAY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Accuray (NASDAQ:ARAY)
Insider Ownership Percentage: 2.70%
Institutional Ownership Percentage: 92.55%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2015Joshua LevineCEOBuy50,000$7.12$356,000.00View SEC Filing  
2/2/2015Alaleh NouriSVPSell5,164$7.38$38,110.32View SEC Filing  
11/30/2014Alaleh NouriSVPSell268$6.62$1,774.16View SEC Filing  
11/30/2014Kelly LondyEVPSell2,273$6.62$15,047.26View SEC Filing  
11/3/2014Joshua LevineCEOBuy100,000$6.34$634,000.00View SEC Filing  
5/6/2014Joshua LevineCEOBuy50,000$8.15$407,500.00View SEC Filing  
2/4/2014Richard PettingillDirectorBuy9,795$10.33$101,182.35View SEC Filing  
12/4/2013Jack GoldsteinDirectorSell7,000$7.70$53,900.00View SEC Filing  
12/3/2013Elizabeth DavilaDirectorSell8,000$7.74$61,920.00View SEC Filing  
9/4/2013Darren J MillikenSVPSell11,002$6.53$71,843.06View SEC Filing  
3/5/2013Dennis L WingerDirectorBuy20,000$4.30$86,000.00View SEC Filing  
2/13/2013Joshua LevineCEOBuy100,000$4.38$438,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Accuray (NASDAQ:ARAY)
News IconAccuray Receives Average Recommendation of “Hold” from Analysts - Petro Global News 24 (NASDAQ:ARAY) - September 22 at 3:31 PM logoAccuray to Unveil New Technology at the ASTRO 2016 Annual Meeting (NASDAQ:ARAY) - September 22 at 9:26 AM logoACCURAY INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:ARAY) - September 21 at 8:41 AM
News IconActive Movers in Hot Line: ImmunoGen, Inc. (NASDAQ:IMGN ... - Street Wise Report (press release) (blog) (NASDAQ:ARAY) - September 19 at 4:30 PM
News IconStock in Limelight: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Accuray Incorporated (NASDAQ:ARAY) - Newburgh Press (NASDAQ:ARAY) - September 19 at 4:30 PM logoTechnical Roundup on Healthcare Stocks -- ResMed, MiMedx, Varian Medical Systems, and Accuray - PR Newswire (press release) (NASDAQ:ARAY) - September 16 at 3:33 PM
News IconAccuray Inc. (NASDAQ: ARAY) Stock Coverage Initiated at Cowen ... - The Woodbridge Citizen (NASDAQ:ARAY) - September 14 at 3:35 PM logoAccuray, Inc. breached its 50 day moving average in a Bearish Manner : ARAY-US : September 12, 2016 (NASDAQ:ARAY) - September 12 at 3:33 PM logoETF’s with exposure to Accuray, Inc. : September 7, 2016 (NASDAQ:ARAY) - September 7 at 12:31 PM logoAccuray to Participate in the Morgan Stanley Global Healthcare Conference 2016 (NASDAQ:ARAY) - September 6 at 8:22 AM logoAccuray, Inc. breached its 50 day moving average in a Bearish Manner : ARAY-US : September 2, 2016 (NASDAQ:ARAY) - September 2 at 3:34 PM logoACCURAY INC Financials (NASDAQ:ARAY) - August 30 at 3:32 PM logoAccuray, Inc. :ARAY-US: Earnings Analysis: 2016 By the Numbers : August 30, 2016 (NASDAQ:ARAY) - August 30 at 10:56 AM
News IconBrean Capital Equities Analysts Cut Earnings Estimates for Accuray Inc. (ARAY) (NASDAQ:ARAY) - August 25 at 8:57 PM logoACCURAY INC Files SEC form 10-K, Annual Report (NASDAQ:ARAY) - August 25 at 8:21 AM
News IconInvestor's Alert: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ... - Newburg Press (NASDAQ:ARAY) - August 22 at 3:37 PM logoETF’s with exposure to Accuray, Inc. : August 22, 2016 (NASDAQ:ARAY) - August 22 at 3:37 PM logoHealthcare Unusual Volume: Cerulean Pharma Inc. (NASDAQ:CERU), Accuray Incorporated (NASDAQ:ARAY ... - KC Register (NASDAQ:ARAY) - August 20 at 8:33 AM
News IconThe MRIdian Radiotherapy System - VRAY's promise to shrink the ... - Yahoo Sports (NASDAQ:ARAY) - August 19 at 4:11 PM logoAccuray, Inc. breached its 50 day moving average in a Bearish Manner : ARAY-US : August 19, 2016 (NASDAQ:ARAY) - August 19 at 11:57 AM logoAccuray, Inc. :ARAY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 19, 2016 (NASDAQ:ARAY) - August 19 at 11:57 AM logoAfter-Hours Earnings Report for August 17, 2016 : CSCO, NTES, LB, A, SNPS, NTAP, KEYS, CACI, YY, BGG, ARAY ... - Nasdaq (NASDAQ:ARAY) - August 18 at 9:01 PM logoMid-Day Market Update: Sunedison Semiconductor Surges Following GlobalWafers Buyout; Auris Medical Shares Drop - Nasdaq (NASDAQ:ARAY) - August 18 at 9:01 PM logoMid-Day Market Update: Sunedison Semiconductor Surges Following GlobalWafers Buyout; Auris Medical Shares Drop - Benzinga (NASDAQ:ARAY) - August 18 at 3:43 PM
News IconActive Stocks in 'How' and 'Why'- Accuray (NASDAQ:ARAY), Auris Medical Holding (NASDAQ:EARS), Johnson ... - Seneca Globe (NASDAQ:ARAY) - August 18 at 3:43 PM
News IconMix Cap Volatile Mover: Accuray (NASDAQ:ARAY), Ross Stores (NASDAQ:ROST), Auris Medical (EARS) - Street Wise Report (press release) (blog) (NASDAQ:ARAY) - August 18 at 3:43 PM logoWhy Accuray Incorporated Is Tumbling 12.5% Today (NASDAQ:ARAY) - August 18 at 2:34 PM logoEdited Transcript of ARAY earnings conference call or presentation 17-Aug-16 8:30pm GMT (NASDAQ:ARAY) - August 18 at 11:57 AM logoAccuray (ARAY) Q4 Loss Wider than Expected, Stock Down (NASDAQ:ARAY) - August 18 at 11:57 AM logoAccuray Reports Fourth Quarter and Fiscal 2016 Financial Results (NASDAQ:ARAY) - August 17 at 9:01 PM logoEARNINGS SUMMARY: Details of Accuray Incorporated Q4 Earnings Report (NASDAQ:ARAY) - August 17 at 9:01 PM logoAccuray Incorporated : reports 4Q loss (NASDAQ:ARAY) - August 17 at 9:01 PM logoAccuray reports 4Q loss (NASDAQ:ARAY) - August 17 at 9:01 PM logoAccuray Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:ARAY) - August 17 at 9:01 PM logoWill Accuray (ARAY) Stock Fall on Q4 Miss, Downbeat Outlook? (NASDAQ:ARAY) - August 17 at 9:01 PM logoEarnings Reaction History: Accuray Incorporated, 100.0% Follow-Through Indicator, 9.0% Sensitive - Nasdaq (NASDAQ:ARAY) - August 17 at 3:36 PM logoQ4 2016 Accuray Inc Earnings Release - After Market Close (NASDAQ:ARAY) - August 17 at 11:46 AM logoVerisk Health Names Dr. Emad Rizk CEO and Board Director - Business Wire (press release) (NASDAQ:ARAY) - August 16 at 8:50 PM logoVerisk Health Names Dr. Emad Rizk CEO and Board Director - Yahoo Finance (NASDAQ:ARAY) - August 16 at 3:35 PM
News IconPE-backed Verisk Health recruits Rizk as CEO - PE HUB - PE Hub (subscription) (blog) (NASDAQ:ARAY) - August 15 at 9:05 PM logoAccuray Expands Product Portfolio, Radixact Now CE-Marked (NASDAQ:ARAY) - August 12 at 12:08 PM logoShort Interest In Accuray Expands By 10.6% (NASDAQ:ARAY) - August 10 at 3:54 PM
News IconAccuray CE Marks Its New Radixact(TM) System (NASDAQ:ARAY) - August 9 at 12:21 PM
News IconAccuray CE Marks its New Radixact System (NASDAQ:ARAY) - August 9 at 12:21 PM logo6:32 am Accuray has CE marked its Radixact Treatment Delivery System (NASDAQ:ARAY) - August 9 at 12:21 PM logoAccuray CE Marks its New Radixact™ System (NASDAQ:ARAY) - August 9 at 12:21 PM logoHitachi : August 4, 2016Hitachi and Mitsubishi Heavy Industries agree to transfer X Radiation Therapy Equipment Business (NASDAQ:ARAY) - August 8 at 8:21 AM logoAccuray (ARAY) Announces Presentation of New, Positive TomoTherapy Data (NASDAQ:ARAY) - August 6 at 11:18 AM logoPRIMECAP Sells Portions of 3 Stakes - Nasdaq (NASDAQ:ARAY) - August 4 at 3:39 PM logoNew Data Demonstrating TomoTherapy® System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists (NASDAQ:ARAY) - August 4 at 12:04 PM


Accuray (NASDAQ:ARAY) Chart for Sunday, September, 25, 2016

Last Updated on 9/25/2016 by Staff